Text Size:AAA

Human IFNA5/IFNaG  Protein

All IFNA5 Reagents

IFNA5/IFNaG
Description: Active  
Expression host: Human Cells  
10342-H01H-50
10342-H01H-5
10342-H01H-100
50 µg 
5 µg 
100 µg 
Add to Cart
  • Slide 1

Browse IFNA5/IFNaG Products by

IFNA5/IFNaG Related Area

IFNA5/IFNaG Related Pathways

    IFNA5/IFNaG Related Protein, Antibody, cDNA Gene, and ELISA Kits

    IFNA5/IFNaG Related Protein, Antibody, cDNA Gene, and ELISA Kits

    Featured Reagent Products

    IFNA5/IFNaG Summary & Protein Information

    IFNA5/IFNaG Related Information

    IFNA5/IFNaG Background

    Subcellular location: Secreted.
    Sequence similarity: Belongs to the alpha/beta interferon family. {ECO:0000305}.
    General information above from UniProt

    Interferon, alpha 5 (IFNA5) belongs to the alpha/beta interferon family. IFNA5 is the only IFNA subtype detected in normal liver, while a mixture of subtypes is observed in the liver tissue of patients with chronic hepatitis C. Interferons are produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. IFN-alpha, the first cytokine to be produced by recombinant DNA technology, has emerged as an important regulator of growth and differentiation, affecting cellular communication and signal transduction pathways as well as immunological control. Originally discovered as an antiviral substance, the efficacy of IFN-alpha in malignant, viral, immunological, angiogenic, inflammatory, and fibrotic diseases suggests a spectrum of interrelated pathophysiologies. IFN-alpha emerged as a prototypic tumor suppressor protein that represses the clinical tumorigenic phenotype in some malignancies capable of differentiation.

    IFNA5/IFNaG Alternative Name

    IFNA5/IFNaG Related Studies

  • Lau JY, et al. (1993) Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet. 342(8881): 1208-9.
  • Kessler DS, et al. (1990) Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 4(10): 1753-65.
  • Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci U S A. 91(4): 1198-205.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"